World Investment Advisors Boosts Stake in iShares Biotechnology ETF $IBB

World Investment Advisors boosted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 50.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,853 shares of the financial services provider’s stock after buying an additional 3,973 shares during the period. World Investment Advisors’ holdings in iShares Biotechnology ETF were worth $2,000,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of IBB. BNP Paribas Financial Markets lifted its holdings in iShares Biotechnology ETF by 313.2% during the third quarter. BNP Paribas Financial Markets now owns 1,915,395 shares of the financial services provider’s stock worth $276,526,000 after buying an additional 1,451,820 shares during the period. WestEnd Advisors LLC purchased a new stake in iShares Biotechnology ETF during the fourth quarter worth $106,276,000. Truist Financial Corp lifted its holdings in iShares Biotechnology ETF by 2,239.6% during the fourth quarter. Truist Financial Corp now owns 642,023 shares of the financial services provider’s stock worth $108,354,000 after buying an additional 614,582 shares during the period. Jefferies Financial Group Inc. purchased a new stake in iShares Biotechnology ETF during the third quarter worth $65,083,000. Finally, JPMorgan Chase & Co. lifted its holdings in iShares Biotechnology ETF by 27.2% during the third quarter. JPMorgan Chase & Co. now owns 1,060,048 shares of the financial services provider’s stock worth $153,039,000 after buying an additional 226,852 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $166.83 on Friday. The business has a fifty day moving average of $169.24 and a two-hundred day moving average of $169.57. iShares Biotechnology ETF has a twelve month low of $118.51 and a twelve month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were issued a dividend of $0.1218 per share. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.